MARGARET GOODELL to Hematologic Neoplasms
This is a "connection" page, showing publications MARGARET GOODELL has written about Hematologic Neoplasms.
Connection Strength
2.665
-
PPM1D in Solid and Hematologic Malignancies: Friend and Foe? Mol Cancer Res. 2022 09 02; 20(9):1365-1378.
Score: 0.657
-
Dnmt3a loss and Idh2 neomorphic mutations mutually potentiate malignant hematopoiesis. Blood. 2020 03 12; 135(11):845-856.
Score: 0.553
-
DNMT3A in haematological malignancies. Nat Rev Cancer. 2015 Mar; 15(3):152-65.
Score: 0.390
-
Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation. Blood. 2015 Jan 22; 125(4):629-38.
Score: 0.388
-
Perspectives and future directions for epigenetics in hematology. Blood. 2013 Jun 27; 121(26):5131-7.
Score: 0.345
-
Antibiotic treatment ameliorates Ten-eleven translocation 2 (TET2) loss-of-function associated hematological malignancies. Cancer Lett. 2019 12 28; 467:1-8.
Score: 0.134
-
Oncometabolite d-2-hydroxyglutarate impairs a-ketoglutarate dehydrogenase and contractile function in rodent heart. Proc Natl Acad Sci U S A. 2016 09 13; 113(37):10436-41.
Score: 0.108
-
Hematopoietic stem cell development: an epigenetic journey. Curr Top Dev Biol. 2014; 107:39-75.
Score: 0.090